The Reduction in Medical and Care Costs for Diseases Associated with Being Bedridden in Rural Residents in Japan
Speaker(s)
Shoji A1, Kudo KI2, Murashita K2, Nakaji S2, Igarashi A3
1Healthcare Consulting Inc., Bunkyo-ku, 13, Japan, 2Hirosaki University, Hirosaki, Aomori, Japan, 3Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
OBJECTIVES: We previously showed that the Center for Healthy Aging Program (CHAP) in a Japanese rural area, Hirosaki, is associated with the reduction of cardiovascular-disease-related costs. This study aims to assess the effect of the CHAP on the medical and care costs for diseases related to being bedridden.
METHODS: We compared the all-cause medical and care costs in patients diagnosed as dementia, stroke, or a fracture in the period from 1st July 2015 to 30th June 2019 (follow-up) using the claims data of residents in Hirosaki between three groups, identified by the participation of checkups during a year before the follow-up period (baseline): CHAP participants (CHAP group), residents who received an annual standard health checkup (SHC) group, and everyone else (no checkup group). We used a multivariate hurdle model considering age, sex, care level, and Charlson Comorbidity Index to adjust the difference in baseline characteristics.
RESULTS: Of 42,819 eligible residents, the numbers of those in the CHAP, SHC, and no checkup groups were 384 (0.9%), 9,805 (22.9%), and 32,630 (76.2%), respectively. The all-cause medical costs in the follow-up period were lowest in the CHAP group for all three diseases. In patients with a fracture, both all-cause care costs in the follow-up period and in the year before the follow-up end were lower in the CHAP group than in the no checkup group (risk ratio [RR] = 0.097, p = 0.022 and RR = 0.091, p = 0.018, respectively), but in patients with dementia, the former were not different while the latter were lower in the CHAP group (RR = 0.365, p = 0.233 and RR = 0.086, p < 0.001, respectively).
CONCLUSIONS: We observed the high reduction of care costs for patients with bedridden-associated diseases in the CHAP group, especially in the last year of the follow-up, suggesting the long-term effect of the CHAP.
Code
EE427
Topic
Economic Evaluation, Epidemiology & Public Health, Study Approaches
Topic Subcategory
Prospective Observational Studies, Public Health
Disease
Cardiovascular Disorders (including MI, Stroke, Circulatory), Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal), Neurological Disorders